Todd Lewis Talarico
Corporate Officer/Principal bei IMMUNOGEN, INC.
Profil
Todd Lewis Talarico is currently the Chief Commercial Officer & VP-Market Access at ImmunoGen, Inc. He previously worked as the Director-Product Development at Apex Bioscience, Inc., Vice President-Process Development at Medicago, Inc., and Principal at AlphaVax, Inc. Talarico holds a doctorate degree from North Carolina State University and an undergraduate degree from The Pennsylvania State University.
Aktive Positionen von Todd Lewis Talarico
Unternehmen | Position | Beginn |
---|---|---|
IMMUNOGEN, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Todd Lewis Talarico
Unternehmen | Position | Ende |
---|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Corporate Officer/Principal | 01.11.2018 |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Apex Bioscience, Inc.
Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Corporate Officer/Principal | - |
Ausbildung von Todd Lewis Talarico
North Carolina State University | Doctorate Degree |
The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IMMUNOGEN, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Apex Bioscience, Inc.
Apex Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Apex Bioscience, Inc. develops patented products based upon hemoglobin and nitric oxide technologies. The company was founded by Joseph de Angelo on June 17, 1993 and is headquartered in Chapel Hill, NC. | Commercial Services |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
AlphaVax, Inc.
AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Health Technology |